Life-time anxiety disorders in patients with late-onset psychosis

Maria A. Savina , Vladimir S. Sheshenin , Valeriya V. Pochueva

Neurology Bulletin ›› 2022, Vol. LIV ›› Issue (2) : 13 -22.

PDF
Neurology Bulletin ›› 2022, Vol. LIV ›› Issue (2) : 13 -22. DOI: 10.17816/nb87487
Original study arcticles
research-article

Life-time anxiety disorders in patients with late-onset psychosis

Author information +
History +
PDF

Abstract

BACKGROUND. Anxiety disorders are frequently observed in patients with schizophrenia. Meanwhile lifetime frequency of these disorders in late-onset schizophrenia remains unknown.

AIM. The aim of the study was to investigate frequency of anxiety disorders in patients with late-onset psychosis.

MATERIAL AND METHODS. 85 patients with late-manifesting psychoses (after 40 years) aged 45 to 86 years (average age 66.5=9.5 years) were examined. Patients with late schizophrenia (n=42), late schizoaffective disorder (n=12), late chronic delusional disorder (n=15), organic schizoform psychosis (n=8), recurrent depression with psychotic symptoms (n=8) underwent psychiatric examination (PANSS, HDRS-17, MMSE, MoCA) and standard interviews. The diagnosis was carried out according to the criteria of the International Classification of Diseases of the 10th revision. The control group included 24 people over 45 years old without signs of mental disorders (average age 57.6±8.8 years). Statistical analysis included nonparametric criteria.

RESULTS. Results. Patients with late schizophrenia were distinguished by certain premorbid features in the form of an increased frequency of social phobia, more animal phobias and multiple polysymptomatic habitual anxiety reactions. Patients with late schizoaffective disorder were characterized by a tendency to hypochondriac fears and multiple polysymptomatic habitual anxiety reactions. Patients with late delusional disorder were characterized by an increased frequency of animal phobias. Patients with late mental depression are characterized by the presence of multiple undeveloped anxiety reactions and hypochondriac fears. Patients with endomorphic organic psychoses were distinguished by a low frequency of hypochondriacal fears in the anamnesis.

CONCLUSION. High frequency of anxiety disorders in patients with late-onset schizophrenia was detected. This data could improve diagnostics of late-onset psychosis.

Keywords

late-onset psychosis / late-onset schizophrenia / late-onset schizoaffective disorder / social phobia / phobia / anxiety / generalized anxiety disorder

Cite this article

Download citation ▾
Maria A. Savina, Vladimir S. Sheshenin, Valeriya V. Pochueva. Life-time anxiety disorders in patients with late-onset psychosis. Neurology Bulletin, 2022, LIV(2): 13-22 DOI:10.17816/nb87487

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Achim AM, Maziade M, Raymond E et al. How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association. Schizophr Bull. 2011;37(4):811–821. DOI: 10.1093/schbul/sbp148.

[2]

Achim A.M., Maziade M., Raymond E. et al. How prevalent are anxiety disorders in schizophrenia? A meta-analysis and cri-tical review on a significant association // Schizophr. Bull. 2011. Vol. 37. N. 4. Р. 811–821. DOI: 10.1093/schbul/sbp148.

[3]

Lowengrub KM, Stryjer R, Birger M, Iancu I. Social anxiety disorder comorbid with schizophrenia: The importance of screening for this under recognized and under treated condition. Isr J Psychiatry Relat Sci. 2015;52(1):40–45.

[4]

Lowengrub K.M., Stryjer R., Birger M., Iancu I. Social anxiety disorder comorbid with schizophrenia: The importance of screening for this under recognized and under treated condition // Isr. J. Psychiatry Relat. Sci. 2015. Vol. 52. N. 1. Р. 40–45.

[5]

Roy MA, Demers MF, Achim AM. Social anxiety disorder in schizophrenia: a neglected, yet potentially important comorbidity. J Psychiatry Neurosci. 2018;43(4):287–288. DOI: 10.1503/jpn.180081.

[6]

Roy M.A., Demers M.F., Achim A.M. Social anxiety disorder in schizophrenia: a neglected, yet potentially important comorbidity // J. Psychiatry Neurosci. 2018. Vol. 43. N. 4. Р. 287–288. DOI: 10.1503/jpn.180081.

[7]

Mazeh D, Bodner E, Weizman R et al. Co-morbid social phobia in schizophrenia. Int J Soc Psychiatry. 2009;55(3):198–202. DOI: 10.1177/0020764008093447.

[8]

Mazeh D., Bodner E., Weizman R. et al. Co-morbid social phobia in schizophrenia // Int. J. Soc. Psychiatry. 2009. Vol. 55. N. 3. Р. 198–202. DOI: 10.1177/0020764008093447.

[9]

Vrbova K, Prasko J, Ociskova M, Holubova M. Comorbidity of schizophrenia and social phobia — impact on quality of life, hope, and personality traits: a cross sectional study. Neuropsychiatr Dis Treat. 2017;13:2073–2083. DOI: 10.2147/NDT.S141749.

[10]

Vrbova K., Prasko J., Ociskova M., Holubova M. Comorbidity of schizophrenia and social phobia — impact on quality of life, hope, and personality traits: a cross sectional study // Neuropsychiatr. Dis. Treat. 2017. Vol. 13. Р. 2073–2083. DOI: 10.2147/NDT.S141749.

[11]

Picado M, Carmona S, Hoekzema E et al. The neuroanatomical basis of panic disorder and social phobia in schizophrenia: a voxel based morphometric study. PLoS One. 2015;10(3):e0119847. DOI: 10.1371/journal.pone.0119847.

[12]

Picado M., Carmona S., Hoekzema E. et al. The neuroanato-mical basis of panic disorder and social phobia in schizophrenia: a voxel based morphometric study // PLoS One. 2015. Vol. 10. N. 3. P. e0119847. DOI: 10.1371/journal.pone.0119847.

[13]

Chugunov DA, Shmilovich AA. Psihopatologicheskie osobennosti trevozhno-fobicheskih rasstrojstv, posluzhivshih povodom dlja gospitalizacii v psihiatricheskij stacionar. Zhurnal nevrologii i psihiatrii im. C.C. Korsakova. 2017;117(11):18–23. DOI 10.17116/jnevro201711711118-23. (In Russ.)

[14]

Чугунов Д.А., Шмилович А.А. Психопатологические особенности тревожно-фобических расстройств, послуживших поводом для госпитализации в психиатрический стационар // Журнал неврологии и психиатрии им. C.C. Корсакова. 2017. Т. 117. №11. С. 18–23. DOI: 10.17116/jnevro201711711118-23.

[15]

Bobrov AS, Pavlova ON. Fobicheskie rasstrojstva v klinike shizofrenii s pristupoobraznym tipom techenija. Sibirskij medicinskij zhurnal (Irkutsk). 2011;105(6):99–102. (In Russ.)

[16]

Бобров А.С., Павлова О.Н. Фобические расстройства в клинике шизофрении с приступообразным типом течения // Сибирский медицинский журнал (Иркутск). 2011. Т. 105. №6. С. 99–102.

[17]

Pavlichenko AV. Mnozhestvennye trevozhno-fobicheskie i obessivno-kompul’sivnye rasstrojstva pri shizofrenii. Social’naja i klinicheskaja psihiatrija. 2007;17(2):33–37. (In Russ.)

[18]

Павличенко А.В. Множественные тревожно-фобические и обессивно-компульсивные расстройства при шизофрении // Социальная и клиническая психиатрия. 2007. Т. 17. №2. С. 33–37.

[19]

Savina МА, Serpuhovitina IА. Increased risk of minor post-stroke depression with damage to the subcortical structures of the right hemisphere. Psikhicheskoe zdorovie. 2019;(11):35–43. (In Russ.)

[20]

Савина М.А., Серпуховитина И.А. Повышение риска малых постинсультных депрессией при поражении подкорковых структур правого полушария // Психическое здоровье. 2019. №11. С. 35–43.

[21]

Kolyutskaya EV. Sotsialnie fobii i osnovnie podkhodi k ikh terapii. Shizofreniya i rasstroystva shizofrenicheskogo spektra. Pod red AB Smulevicha. M.: Meditsina; 1999. р. 283–284. (In Russ.)

[22]

Колюцкая Е.В. Социальные фобии и основные подходы к их терапии. Шизофрения и расстройства шизофренического спектра. Под ред. А.Б. Смулевича. М.: Медицина; 1999. с. 283–284.

[23]

Ohi K, Shimada T, Nitta Y et al. The Five-Factor Model personality traits in schizophrenia: A meta-analysis. Psychiatry Res. 2016;240:34–41. DOI: 10.1016/j.psychres.2016.04.004.

[24]

Ohi K., Shimada T., Nitta Y. et al. The Five-Factor Model personality traits in schizophrenia: A meta-analysis // Psychiatry Res. 2016. Vol. 240. Р. 34–41. DOI: 10.1016/j.psychres.2016.04.004.

[25]

Sharma SC. Generalized anxiety disorder and personality traits. Kathmandu Univ Med J (KUMJ). 2003;1(4):248–250. PMID: 16388264.

[26]

Sharma S.C. Generalized anxiety disorder and personality traits // Kathmandu Univ. Med. J. (KUMJ). 2003. Vol. 1. N. 4. P. 248–250. PMID: 16388264.

[27]

Prince EJ, Siegel DJ, Carroll CP et al. A longitudinal study of personality traits, anxiety, and depressive disorders in young adults. Anxiety Stress Coping. 2021;34(3):299–307. DOI: 10.1080/10615806.2020.1845431.

[28]

Prince E.J., Siegel D.J., Carroll C.P. et al. A longitudinal study of personality traits, anxiety, and depressive disorders in young adults // Anxiety Stress Coping. 2021. Vol. 34. N. 3. P. 299–307. DOI: 10.1080/10615806.2020.1845431.

[29]

Serebrjakova EV. Nevropatija i shizotipicheskoe rasstrojstvo lichnosti (klinicheskie aspekty). Psihiatrija (nauchno-prakticheskij zhurnal). 2005;02(14):27–32. (In Russ.)

[30]

Серебрякова Е.В. Невропатия и шизотипическое расстройство личности (клинические аспекты) // Психиатрия (научно-практический журнал). 2005. Т. 02. №14. С. 27–32.

[31]

Rado S. Dynamics and classification of disordered behavior. Am J Psychiatry. 1953;110:6:406–416. DOI: 10.1176/ajp.110.6.406.

[32]

Rado S. Dynamics and classification of disordered behavior // Am. J. Psychiatry. 1953. Vol. 110. N. 6. P. 406–416. DOI: 10.1176/ajp.110.6.406.

[33]

Kernberg OF. Psychotic personality structure. Psychodyn Psychiatry. 2019;47(4):353–372. DOI: 10.1521/pdps.2019.47.4.353.

[34]

Kernberg O.F. Psychotic personality structure // Psychodyn. Psychiatry. 2019. Vol. 47. N. 4. P. 353–372. DOI: 10.1521/pdps.2019.47.4.353.

[35]

Winnicott DW. Fear of breakdown. Psyche (Stuttg). 1991;45(12):1116–1126. (In German.) PMID: 1775645.

[36]

Winnicott D.W. Die Angst vor dem Zusammenbruch // Psyche (Stuttg). 1991. Vol. 45. N. 12. P. 1116–1126. PMID: 1775645.

[37]

Klein M. The importance of symbol-formation in the deve-lopment of the ego. Intern J Psycho-Analysis. 1930;11:24–39.

[38]

Klein M. The importance of symbol-formation in the deve-lopment of the ego // International Journal of Psycho-Analysis. 1930. Vol. 11. P. 24–39.

[39]

Winnicott DW. Psychoses and child care. Br J Med Psychol. 1953;26(1):68–74. DOI: 10.1111/j.2044-8341.1953.tb00810.x.

[40]

Winnicott D.W. Psychoses and child care // Br. J. Med. Psychol. 1953. Vol. 26. N. 1. P. 68–74. DOI: 10.1111/j.2044-8341.1953.tb00810.x.

[41]

McEvoy B, O’Connor J, McCarthy O. Behind the mask: A psychodynamic exploration of the experiences of individuals diagnosed with social anxiety disorder. Psychodyn Psychiatry. 2016;44(4):541–565. DOI: 10.1521/pdps.2016.44.4.541.

[42]

McEvoy B., O’Connor J., McCarthy O. Behind the mask: A psychodynamic exploration of the experiences of individuals diagnosed with social anxiety disorder // Psychodyn. Psychiatry. 2016. Vol. 44. N. 4. P. 541–565. DOI: 10.1521/pdps.2016.44.4.541.

[43]

Hall J. Schizophrenia — an anxiety disorder? Br J Psychiatry. 2017;211(5):262–263. DOI: 10.1192/bjp.bp.116.195370. PMID: 29092833.

[44]

Hall J. Schizophrenia — an anxiety disorder? // Br. J. Psychiatry. 2017. Vol. 211. N. 5. P. 262–263. DOI: 10.1192/bjp.bp.116.195370. PMID: 29092833.

[45]

Ermsley RA, Stein DJ. Anxiety and schizophrenia. In: Anxiety disorders. Edited by DJ Nutt, JC Ballenger. Oxford: Blackwell Science; 2003. p. 163–179.

[46]

Ermsley R.A., Stein D.J. Anxiety and schizophrenia. In: Anxiety disorders. Edited by D.J. Nutt, J.C. Ballenger. Oxford: Blackwell Science; 2003. P. 163–179.

[47]

Bourin M, Malinge M, Vasar E, Bradwejn J. Two faces of cholecystokinin: anxiety and schizophrenia. Fundam Clin Pharmacol. 1996;10(2):116–126. DOI: 10.1111/j.1472-8206.1996.tb00154.x. PMID: 8737954.

[48]

Bourin M., Malinge M., Vasar E., Bradwejn J. Two faces of cholecystokinin: anxiety and schizophrenia // Fundam. Clin. Pharmacol. 1996. Vol. 10. N. 2. P. 116–126. DOI: 10.1111/j.1472-8206.1996.tb00154.x. PMID: 8737954.

[49]

Goh KK, Chen CH, Lane HY. Oxytocin in schizophrenia: Pathophysiology and implications for future treatment. Int J Mol Sci. 2021;22(4):2146. DOI: 10.3390/ijms22042146. PMID: 33670047; PMCID: PMC7926349.

[50]

Goh K.K., Chen C.H., Lane H.Y. Oxytocin in schizophrenia: Pathophysiology and implications for future treatment // Int. J. Mol. Sci. 2021. Vol. 22. N. 4. P. 2146. DOI: 10.3390/ijms22042146. PMID: 33670047. PMCID: PMC7926349.

[51]

Yoon S, Kim YK. The role of the oxytocin system in anxiety disorders. Adv Exp Med Biol. 2020;1191:103–120. DOI: 10.1007/978-981-32-9705-0_7. PMID: 32002925.

[52]

Yoon S., Kim Y.K. The role of the oxytocin system in anxiety disorders // Adv. Exp. Med. Biol. 2020. Vol. 1191. P. 103–120. DOI: 10.1007/978-981-32-9705-0_7. PMID: 32002925.

[53]

Rosso IM, Makris N, Britton JC et al. Anxiety sensitivity correlates with two indices of right anterior insula structure in specific animal phobia. Depress Anxiety. 2010;27(12):1104–1110. DOI: 10.1002/da.20765. PMID: 21132846. PMCID: PMC3010373.

[54]

Rosso I.M., Makris N., Britton J.C. et al. Anxiety sensitivity correlates with two indices of right anterior insula structure in specific animal phobia // Depress. Anxiety. 2010. Vol. 27. N. 12. P. 1104–1110. DOI: 10.1002/da.20765. PMID: 21132846. PMCID: PMC3010373.

[55]

Amodio A, Quarantelli M, Mucci A et al. Avolition-apathy and white matter connectivity in schizophrenia: Reduced fractional anisotropy between amygdala and insular cortex. Clin EEG Neurosci. 2018;49(1):55–65. DOI: 10.1177/1550059417745934. PMID: 29243529.

[56]

Amodio A., Quarantelli M., Mucci A. et al. Avolition-apathy and white matter connectivity in schizophrenia: Reduced fractional anisotropy between amygdala and insular cortex // Clin. EEG Neurosci. 2018. Vol. 49. N. 1. P. 55–65. DOI: 10.1177/1550059417745934. PMID: 29243529.

[57]

Porta-Casteràs D, Fullana MA, Tinoco D et al. Prefrontal-amygdala connectivity in trait anxiety and generalized anxiety disorder: Testing the boundaries between healthy and patholo-gical worries. J Affect Disord. 2020;267:211–219. DOI: 10.1016/j.jad.2020.02.029. PMID: 32217221.

[58]

Porta-Casteràs D., Fullana M.A., Tinoco D. et al. Prefrontal-amygdala connectivity in trait anxiety and generalized anxiety disorder: Testing the boundaries between healthy and patholo-gical worries // J. Affect. Disord. 2020. Vol. 267. P. 211–219. DOI: 10.1016/j.jad.2020.02.029. PMID: 32217221.

[59]

Tsuang MT, Stone WS, Auster TL. Prevention of schizophrenia. Expert Rev Neurother. 2010;10(7):1165–1174. DOI: 10.1586/ern.10.87. PMID: 20586696.

[60]

Tsuang M.T., Stone W.S., Auster T.L. Prevention of schizophrenia // Expert Rev. Neurother. 2010. Vol. 10. N. 7. P. 1165–1174. DOI: 10.1586/ern.10.87. PMID: 20586696.

[61]

Meisenzahl E, Walger P, Schmidt SJ et al. Early recognition and prevention of schizophrenia and other psychoses. Nervenarzt. 2020;91(1):10–17. (In German.) DOI: 10.1007/s00115-019-00836-5. PMID: 31858162.

[62]

Meisenzahl E., Walger P., Schmidt S.J. et al. Früherkennung und Prävention von Schizophrenie und anderen Psychosen // Nervenarzt. 2020. Vol. 91. N. 1. P. 10–17. DOI: 10.1007/s00115-019-00836-5. PMID: 31858162.

RIGHTS & PERMISSIONS

Savina M.A., Sheshenin V.S., Pochueva V.V.

AI Summary AI Mindmap
PDF

119

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/